Denali Therapeutics Inc.

DNLI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001714899

SEC filings (opens in a new tab)

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Denali Therapeutics Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of DNLI: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Of which not filed for Q3 2022	Q3 2022	Change
Holders	188	1	200	+13
Shares	92.7M	176	92.4M	−257.0K (−0.3%)
Value	$2.73B	$5.00K	$2.84B	+$108.6M (+4.0%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Denali Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DNLI in Q3 2022
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	633,000	$19.4M	0.08%
T. Rowe Price Investment Management, Inc.	422,357	$13.0M	0.01%
Teachers Retirement System of the State of Kentucky	177,196	$5.44M	0.06%
Castleark Management LLC	127,460	$3.91M	0.22%
Integral Health Asset Management, LLC	115,000	$3.53M	0.72%
Connor, Clark & Lunn Investment Management Ltd.	112,532	$3.45M	0.02%
Capital Research Global Investors	87,767	$2.65M	0.00%
Man Group plc	34,421	$1.06M	0.00%
Bellevue Group AG	31,000	$951.0K	0.01%
Jackson Creek Investment Advisors LLC	27,381	$840.0K	0.39%
Hillsdale Investment Management Inc.	25,700	$789.0K	0.07%
Trexquant Investment LP	25,629	$787.0K	0.03%
Wellington Management Group LLP	21,694	$666.0K	0.00%
Duality Advisers, LP	19,728	$605.0K	0.07%
Arrowstreet Capital, Limited Partnership	18,725	$575.0K	0.00%
HighTower Advisors, LLC	18,823	$573.0K	0.00%
Fox Run Management, L.L.C.	14,977	$460.0K	0.18%
Squarepoint Ops LLC	13,365	$410.0K	0.00%
NinePointTwo Capital	13,171	$404.0K	0.16%
Virginia Retirement Systems Et Al	13,000	$399.0K	0.00%
XTX Topco Ltd	12,023	$369.0K	0.09%
VELA Investment Management, LLC	8,841	$271.0K	0.15%
HSBC Holdings PLC	7,674	$239.0K	0.00%
Algert Global LLC	7,634	$234.0K	0.01%
Dynamic Technology Lab Private Ltd	7,140	$219.0K	0.02%
Point72 Hong Kong Ltd	4,753	$146.0K	0.01%
Simplex Trading, LLC	3,450	$105.0K	0.00%
China Universal Asset Management Co., Ltd.	1,155	$35.0K	0.01%
Assetmark, Inc	438	$13.0K	0.00%
Quadrant Capital Group LLC	50	$2.00K	0.00%
Capital Advisors, Ltd. LLC	6	$0	0.00%
Ronald Blue Trust, Inc.	6	$0	0.00%

Sold out (19)

Institutions that held Denali Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DNLI in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
D. E. Shaw & Co., Inc.	86,113	$2.53M
Engineers Gate Manager LP	17,320	$510.0K
Tudor Investment Corp Et Al	16,464	$485.0K
Jane Street Group, LLC	13,923	$410.0K
Utah Retirement Systems	11,600	$341.0K
Occudo Quantitative Strategies LP	10,672	$314.0K
Fred Alger Management, LLC	8,983	$264.0K
Bridgewater Associates, LP	8,660	$255.0K
GAM Holding AG	8,403	$247.0K
Group One Trading, L.P.	3,522	$104.0K
Brown Brothers Harriman & Co	1,524	$45.0K
Patriot Financial Group Insurance Agency, LLC	800	$24.0K
Captrust Financial Advisors	146	$4.00K
TCI Wealth Advisors, Inc.	114	$3.00K
Hoey Investments, Inc	100	$3.00K
Asset Management One Co.,Ltd.	100	$2.00K
Farmers & Merchants Investments Inc	58	$2.00K
Central Trust Co	4	$0
State of Wyoming	8	$0

Not filed for Q3 2022 yet (1)

Institutions that held Denali Therapeutics Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNLI in Q2 2022 that haven't filed for Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Private Capital Group, LLC	176	$5.00K